# Soichi Fumita

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/soichi-fumita/

## Facts

| Field | Value |
| --- | --- |
| Citations | 832 |
| Field | Gastrointestinal motility and disorders |
| h-index | 13 |
| i10-index | 16 |
| Last Known Institution | Kishiwada City Hospital |
| OpenAlex ID | https://openalex.org/A5018927191 |
| ORCID iD | 0000-0003-0253-0681 |
| Works | 41 |

## Researcher papers

- [Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4)](https://scholariq.org/papers/safety-and-efficacy-of-nivolumab-in-combination-with-s-1-capecitabine-plus/)
- [Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors](https://scholariq.org/papers/clinical-application-of-the-foundationone-cdx-assay-to-therapeutic-decision/)
- [Roles of BIM induction and survivin downregulation in lapatinib-induced apoptosis in breast cancer cells with HER2 amplification](https://scholariq.org/papers/roles-of-bim-induction-and-survivin-downregulation-in-lapatinib-induced/)
- [Incidence of opioid‐induced constipation in Japanese patients with cancer pain: A prospective observational cohort study](https://scholariq.org/papers/incidence-of-opioid-induced-constipation-in-japanese-patients-with-cancer-pain-a/)
- [High-dose dexamethasone plus antihistamine prevents colorectal cancer patients treated with modified FOLFOX6 from hypersensitivity reactions induced by oxaliplatin](https://scholariq.org/papers/high-dose-dexamethasone-plus-antihistamine-prevents-colorectal-cancer-patients/)
- [Chronic nicotine exposure mediates resistance to EGFR-TKI in EGFR -mutated lung cancer via an EGFR signal](https://scholariq.org/papers/chronic-nicotine-exposure-mediates-resistance-to-egfr-tki-in-egfr-mutated-lung/)
- [Sweat-gland carcinoma with neuroendocrine differentiation (SCAND): a clinicopathologic study of 13 cases with genetic analysis](https://scholariq.org/papers/sweat-gland-carcinoma-with-neuroendocrine-differentiation-scand-a/)
- [Safety and efficacy of cetuximab-containing chemotherapy after immune checkpoint inhibitors for patients with squamous cell carcinoma of the head and neck: a single-center retrospective study](https://scholariq.org/papers/safety-and-efficacy-of-cetuximab-containing-chemotherapy-after-immune-checkpoint/)
- [Glasgow Prognostic Score (GPS) and Tumor Response as Biomarkers of Nivolumab Monotherapy in Third- or Later-line Setting for Advanced Gastric Cancer](https://scholariq.org/papers/glasgow-prognostic-score-gps-and-tumor-response-as-biomarkers-of-nivolumab/)
- [Patients' Self-Assessment of the Symptoms and Impact of Opioid-Induced Constipation: Results From a Prospective Observational Cohort Study of Japanese Patients With Cancer](https://scholariq.org/papers/patients-self-assessment-of-the-symptoms-and-impact-of-opioid-induced/)
- [Re-biopsy of twelve non small cell lung cancer (NSCLC) cases](https://scholariq.org/papers/re-biopsy-of-twelve-non-small-cell-lung-cancer-nsclc-cases/)

## Researcher topics

- [Gastrointestinal motility and disorders](https://scholariq.org/topics/gastrointestinal-motility-and-disorders/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

## Researcher university

- [Kishiwada City Hospital](https://scholariq.org/institutions/kishiwada-city-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.